Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
321
NCT01702441
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2012
Completion: Dec 31, 2014
NCT02050828
The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema
Phase: Phase 2
Start: Jan 31, 2014
Completion: May 31, 2015
NCT02387788
Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO
Start: Jan 31, 2015
Completion: Apr 30, 2017
NCT02858271
Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778
Phase: Phase 1
Start: Jul 31, 2016
Completion: Jul 31, 2016
NCT02914262
Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers
Start: Aug 31, 2016
Completion: Jan 31, 2017
NCT04284514
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution
Start: May 2, 2019
Completion: Dec 15, 2019